These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35836189)

  • 21. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
    Alexander K; Pogorzelska-Maziarz M; Gerolamo A; Hassen N; Kelly EL; Rising KL
    Subst Abuse Treat Prev Policy; 2021 Aug; 16(1):60. PubMed ID: 34372900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studying how state health services delivery policies can mitigate the effects of disasters on drug addiction treatment and overdose: Protocol for a mixed-methods study.
    Eisenberg MD; McCourt A; Stuart EA; Rutkow L; Tormohlen KN; Fingerhood MI; Quintero L; White SA; McGinty EE
    PLoS One; 2021; 16(12):e0261115. PubMed ID: 34914779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digital Interventions to Save Lives From the Opioid Crisis Prior and During the SARS COVID-19 Pandemic: A Scoping Review of Australian and Canadian Experiences.
    Donnell A; Unnithan C; Tyndall J; Hanna F
    Front Public Health; 2022; 10():900733. PubMed ID: 35903371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N; McDonald K; Stefan C; Beriault DR; Mason K; Barnaby L; Altenberg J; MacDonald RD; Caldwell J; Nisenbaum R; Leece P; Watson TM; Tupper KW; Kufner L; Scheim AI; Werb D;
    Harm Reduct J; 2020 Jan; 17(1):9. PubMed ID: 32204713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergency Department Visits for Nonfatal Opioid Overdose During the COVID-19 Pandemic Across Six US Health Care Systems.
    Soares WE; Melnick ER; Nath B; D'Onofrio G; Paek H; Skains RM; Walter LA; Casey MF; Napoli A; Hoppe JA; Jeffery MM
    Ann Emerg Med; 2022 Feb; 79(2):158-167. PubMed ID: 34119326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tackling the overdose crisis: The role of safe supply.
    Ivsins A; Boyd J; Beletsky L; McNeil R
    Int J Drug Policy; 2020 Jun; 80():102769. PubMed ID: 32446183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply.
    Bonn M; Palayew A; Bartlett S; Brothers TD; Touesnard N; Tyndall M
    J Stud Alcohol Drugs; 2020 Sep; 81(5):556-560. PubMed ID: 33028465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increases in drug overdose deaths in Norway and the United States during the COVID-19 pandemic.
    Friedman J; Gjersing L
    Scand J Public Health; 2023 Feb; 51(1):53-57. PubMed ID: 35120430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Everywhere and for everyone: proportionate universalism as a framework for equitable access to community drug checking.
    Wallace B; van Roode T; Burek P; Hore D; Pauly B
    Harm Reduct J; 2022 Dec; 19(1):143. PubMed ID: 36539747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increases in Naloxone Administrations by Emergency Medical Services Providers During the COVID-19 Pandemic: Retrospective Time Series Study.
    Khoury D; Preiss A; Geiger P; Anwar M; Conway KP
    JMIR Public Health Surveill; 2021 May; 7(5):e29298. PubMed ID: 33999828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study.
    Lew B; Bodkin C; Lennox R; O'Shea T; Wiwcharuk G; Turner S
    Harm Reduct J; 2022 Mar; 19(1):29. PubMed ID: 35313903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lived experiences of frontline healthcare providers offering maternal and newborn services amidst the novel corona virus disease 19 pandemic in Uganda: A qualitative study.
    Kayiga H; Genevive DA; Amuge PM; Ssemata AS; Nanzira RS; Nakimuli A
    PLoS One; 2021; 16(12):e0259835. PubMed ID: 34890417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
    Napoletano S; Basile G; Lo Faro AF; Negro F
    Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motivations for concurrent use of uppers and downers among people who access harm reduction services in British Columbia, Canada: findings from the 2019 Harm Reduction Client Survey.
    Steinberg A; Mehta A; Papamihali K; Lukac CD; Young S; Graham B; Lock K; Fleury M; Buxton JA
    BMJ Open; 2022 May; 12(5):e060447. PubMed ID: 35501101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework.
    Nguyen T; Buxton JA
    Int J Drug Policy; 2021 Jul; 93():103236. PubMed ID: 33838990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
    Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
    Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review.
    Krawczyk N; Fawole A; Yang J; Tofighi B
    Addict Sci Clin Pract; 2021 Nov; 16(1):68. PubMed ID: 34774106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.